Bas Oldenburg

Full Professor

Strategic program(s):

Contact

boldenbu@umcutrecht.nl

Pure profile

Research groups

Inflammatory bowel diseases

Research aim

Our research is focused on the elucidation of the pathogenesis of Inflammatory bowel diseases (IBD), personalized medicine and on a severe complication of IBD: colitis-associated colorectal carcinoma.

Go to group

Molecular and cellular host-microbiota interactions

Research aim

Our research aims to unravel how the products from pathogenic and beneficial bacterial species within the intestinal microbiota contribute to human health and disease.

Go to group

Tissue immunology

Research aim

Our mission is to comprehensively understand, monitor, and target immune-mediated inflammatory diseases such as IBD, AD and systemic autoimmune diseases. We aim to unravel (tissue) immune dysregulation and induce long-lasting disease modification.

Go to group

Recent publications

All publications

Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events Mick J M van Eijs, M Marlot van der Wal, Hedi-Britt Klotškova, Noël M M Dautzenberg, Mark Schuiveling, Rik J Verheijden, Fiona D M van Schaik, Bas Oldenburg, Stefan Nierkens, Karijn P M Suijkerbuijk, Femke van Wijk,
Communications medicine, 2025, vol. 5, p.1-14

The BAMBOO method for correcting batch effects in high throughput proximity extension assays for proteomic studies H M Smits, E M Delemarre, A Pandit, A H Schoneveld, B Oldenburg, F van Wijk, S Nierkens, J Drylewicz
Scientific Reports, 2025, vol. 15

Next-generation IgA-SEQ allows for high-throughput, anaerobic, and metagenomic assessment of IgA-coated bacteria Merel van Gogh, Jonas M Louwers, Anna Celli, Sanne Gräve, Marco C Viveen, Sofie Bosch, Nanne K H de Boer, Rik J Verheijden, Karijn P M Suijkerbuijk, Eelco C Brand, Janetta Top, Bas Oldenburg, Marcel R de Zoete
Microbiome, 2024, vol. 12

Postoperative outcomes of surgical delay in inflammatory bowel disease patients Ellen de Bock, Eline S Herman, Vincent Meij, Thijs A Burghgraef, Bas Oldenburg, Paul M Verheijen, Apollo Pronk, Mando D Filipe, Menno R Vriens, Milan C Richir
Updates in Surgery, 2024, vol. 76, p.1271-1277

Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease Anouk M Wijnands, Bas B L Penning de Vries, Maurice W M D Lutgens, Zeinab Bakhshi, Ibrahim Al Bakir, Laurent Beaugerie, Charles N Bernstein, Ryan Chang-Ho Choi, Nayantara Coelho-Prabhu, Trevor A Graham, Ailsa L Hart, Joren R Ten Hove, Steven H Itzkowitz, Julien Kirchgesner, Erik Mooiweer, Seth R Shaffer, Shailja C Shah, Sjoerd G Elias, Bas Oldenburg,
Clinical Gastroenterology and Hepatology, 2024, vol. 22, p.1697-1708

Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) Reinier C.A. van Linschoten, Fenna M. Jansen, Renske W.M. Pauwels, Lisa J.T. Smits, Femke Atsma, Wietske Kievit, Dirk J. de Jong, Annemarie C. de Vries, Paul J. Boekema, Rachel L. West, Alexander G.L. Bodelier, Ingrid A.M. Gisbertz, Frank H.J. Wolfhagen, Tessa E.H. Römkens, Maurice W.M.D. Lutgens, Adriaan A. van Bodegraven, Bas Oldenburg, Marieke J. Pierik, Maurice G.V.M. Russel, Nanne K. de Boer, Rosalie C. Mallant-Hent, Pieter C.J. ter Borg, Andrea E. van der Meulen-de Jong, Jeroen M. Jansen, Sita V. Jansen, Adrianus C.I.T.L. Tan, C. Janneke van der Woude, Frank Hoentjen, Desirée van Noord, Jildou Hoekstra, Johannes T. Kamphuis, Moniek H.P. Gorter, Aura A.J. van Esch,
The Lancet Gastroenterology and Hepatology, 2023, vol. 8, p.343-355